Mode
Text Size
Log in / Sign up
N/A Completed N=35 Treatment

Development and Evaluation of Rehabilitation Consult for Survivors of Head and Neck Cancer

Source: ClinicalTrials.gov NCT02836769 ↗
Enrolled (actual)
35
Serious AEs
0.0%
Results posted
Sep 2021
Primary outcomePrimary: Change in Functional Assessment of Cancer Therapy - Head and Neck (FACT - H&N) — 3.1; 5.3 score on a scale

Summary

Although evidence exists to support cancer rehabilitation, services are fragmented and rehabilitation professionals are consulted infrequently and often long after treatment ends, when chronicity of problems limits the impact of intervention. Therefore, the objective of this project is to develop, implement, and conduct a pilot evaluation of the Rehabilitation Consult (RC). The RC program goals are to increase knowledge about rehabilitation needs and resources to meet those needs; to establish individualized rehabilitation goals for HNC survivors and personalized action plans to meet those goals; and to provide support to HNC survivors for the implementation and evaluation of action plans. This project consisted of intervention development and pilot evaluation; this trial registration describes the pilot evaluation phase only.

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Functional Assessment of Cancer Therapy - Head and Neck (FACT - H&N)
3.1; 5.3
PRIMARY
Change in Medical Outcome Short Form (36) Health Survey - (SF-36)
3.5; 6.7; 4.3; 2.8
SECONDARY
Change in Goal Performance, Satisfaction, and Self-efficacy
16.6; 37.3; 26.9; 39.2; 18.4; 17.1

Eligibility Criteria

Inclusion Criteria

  • Adult survivors of HNC who have completed active treatment (surgery, radiation, chemotherapy or any combination thereof) within 1-18 months.

Exclusion Criteria

  • Lack of English fluency,
  • Cognitive impairment, or concurrent major degenerative conditions likely to cause functional deterioration, and
  • Known active cancer.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02836769). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search